Vol. 23 No. 4 (2019)
REVIEWS

Removal of electrodes of implanted systems. The state of the problem

PDF (Русский)
  • O. Sapelnikov,
  • A. Kulikov,
  • D. Cherkashin,
  • I. Grishin,
  • O. Nikolaeva,
  • D. Ardus,
  • A. Shiryaev,
  • R. Akchurin
O. Sapelnikov
National Medical Research Center of Cardiology, Moscow
A. Kulikov
National Medical Research Center of Cardiology, Moscow
Bio
D. Cherkashin
National Medical Research Center of Cardiology, Moscow
I. Grishin
National Medical Research Center of Cardiology, Moscow
O. Nikolaeva
National Medical Research Center of Cardiology, Moscow
D. Ardus
National Medical Research Center of Cardiology, Moscow
A. Shiryaev
National Medical Research Center of Cardiology, Moscow
R. Akchurin
National Medical Research Center of Cardiology, Moscow
DOI: https://doi.org/10.21688/1681-3472-2019-4-47-52

Published 2019-12-27

Keywords

  • cardiac implantable device,
  • electrocardiostimulator,
  • electrode extraction,
  • implantable cardioverter-defibrillator

How to Cite

Sapelnikov, O., Kulikov, A., Cherkashin, D., Grishin, I., Nikolaeva, O., Ardus, D., Shiryaev, A., & Akchurin, R. (2019). Removal of electrodes of implanted systems. The state of the problem. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 23(4), 47–52. https://doi.org/10.21688/1681-3472-2019-4-47-52

Copyright (c) 2019 Sapelnikov O. V., Kulikov A. A., Cherkashin D. I., Grishin I. R., Nikolaeva O. A., Ardus D. F., Shiryaev A. A., Akchurin R. S.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The increase in indications for cardiac implantable devices had led to an increase in the number of device implantations worldwide, with a corresponding increase in the incidence of complications. Finally, in 1980, the development of methods for removing problematic leads and devices were first attempted. Currently, an average of 10,000–15,000 extractions/year are performed worldwide. Improving the design and technical performance of device leads has been the goal of several scientific and engineering efforts; however, they occasionally continue to fail, potentially leading to adverse clinical outcomes. The preferred technique is transvenous lead extraction, and over the past few decades, its effectiveness has substantially improved. Nevertheless, the extraction procedure is associated with high risks, and these risks should be considered when deciding on the procedure. The present review discusses the issues associated with determining appropriate strategies to reduce the risks associated with lead extraction and identifying accurate indicators for the removal of cardiac implantable device leads.

Received 17 May 2019. Revised 12 December 2019. Accepted 13 December 2019.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

PDF (Русский)

References

  1. Wilkoff B.L., Love C.J., Byrd C.L., Bongiorni M.G., Carrillo R.G., Crossley G.H. 3rd, Epstein L.M., Friedman R.A., Kennergren C.E., Mitkowski P., Schaerf R.H., Wazni O.M., Heart Rhythm Society; American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085-104. PMID: 19560098. https://doi.org/10.1016/j.hrthm.2009.05.020
  2. Halperin J.L., Levine G.N., Al-Khatib S.M., Birtcher K.K., Bozkurt B., Brindis R.G., Cigarroa J.E., Curtis L.H., Fleisher L.A., Gentile F., Gidding S., Hlatky M.A., Ikonomidis J., Joglar J., Pressler S.J., Wijeysundera D.N. Further evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;67(13):1572-4. PMID: 26409257. https://doi.org/10.1016/j.jacc.2015.09.001
  3. Providencia R., Kramer D.B., Pimenta D., Babu G.G., Hatfield L.A., Ioannou A., Novak J., Hauser R.G., Lambiase P.D. Transvenous implantable cardioverterdefibrillator (ICD) lead performance: a meta-analysis of observational studies. J Am Heart Assoc. 2015;4(11):e002418. PMID: 26518666, PMCID: PMC4845221. https://doi.org/10.1161/JAHA.115.002418
  4. de Voogt W.G. Pacemaker leads: performance and progress. Am J Cardiol. 1999;83(5B):187D-191D. PMID: 10089864. https://doi.org/10.1016/s0002-9149(98)01022-4
  5. Kron J., Herre J., Renfroe E.G., Rizo-Patron C., Raitt M., Halperin B., Gold M., Goldner B., Wathen M., Wilkoff B., Olarte A., Yao Q. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J. 2001;141(1):92-8. PMID: 11136492. https://doi.org/10.1067/mhj.2001.111261
  6. Eckstein J., Koller M.T., Zabel M., Kalusche D., Schaer B.A., Osswald S., Sticherling C. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation. 2008;117(21):2727-33. PMID: 18490526. https://doi.org/10.1161/CIRCULATIONAHA.107.740670
  7. Kleemann T., Becker T., Doenges K., Vater M., Senges J., Schneider S., Saggau W., Weisse U., Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115(19):2474-80. PMID: 17470696. https://doi.org/10.1161/CIRCULATIONAHA.106.663807
  8. Hauser R.G., Kallinen L.M., Almquist A.K., Gornick C.C., Katsiyiannis W.T. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007;4(7):892-896. PMID: 17599673. https://doi.org/10.1016/j.hrthm.2007.03.041
  9. Kallinen L.M., Hauser R.G., Lee K.W., Almquist A.K., Katsiyiannis W.T., Tang C.Y., Melby D.P., Gornick C.C. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2008;5(6):775-9. PMID: 18534361. https://doi.org/10.1016/j.hrthm.2008.02.039
  10. van Rees J.B., van Welsenes G.H., Borleffs C.J.W., Thijssen J., van der Velde E.T., van der Wall E.E., van Erven L., Schalij M.J. Update on small-diameter implantable cardioverter-defibrillator leads performance. Pacing Clin Electrophysiol. 2012;35(6):652-8. PMID: 22352338. https://doi.org/10.1111/j.1540-8159.2011.03338.x
  11. Biotronik Cardiac Rhythm Management Product Performance Report. January 2016. Режим доступа: https://biotronik.cdn.mediamid.com/cdn_bio_doc/bio24356/19113/bio24356.pdf. Дата обращения: 07.08.2016 г. [Available from https://biotronik.cdn.mediamid.com/cdn_bio_doc/bio24356/19113/bio24356.pdf. Accessed 2016 August 7]
  12. Boston Scientific Rhythm Management Product Performance Report 2016, Q2 Edition. Режим доступа: http://www.bostonscientific.com/content/dam/bostonscientific/quality/ppr/2016/Q2/Product%20Performance%20Report%20Q2%202016%20Rev%20B.pdf. Дата обращения: 07.08.2016 г. [Available from http://www.bostonscientific.com/content/dam/bostonscientific/quality/ppr/2016/Q2/Product%20Performance%20Report%20Q2%202016%20Rev%20B.pdf. Accessed 2016 August 7]
  13. Medtronic Cardiac Rhythm and Heart Failure Product Performance Report 2016, First Edition. Режим доступа: http://wwwp.medtronic.com/productperformance-files/Issue%2074%20MDT%20CRHF%20PPR%202016%201st%20Edition.pdf. Дата обращения: 07.08.2016 г. [Available from http://wwwp.medtronic.com/productperformance-files/Issue%2074%20MDT%20CRHF%20PPR%202016%201st%20Edition.pdf. Accessed 2016 August 7]
  14. Sorin Group Cardiac Rhythm Management Product Performance Report May 2016. Режим доступа: http://www.livanova.sorin.com/file/download-5265.action. Дата обращения: 07.08.2016 г. [Available from http://www.livanova.sorin.com/file/download-5265.action. Accessed 2016 August 7]
  15. St. Jude Medical Implantable Electronic Systems Product Performance Report 2016, First Edition. Режим доступа: https://www.sjm.com/w/media/galaxy/hcp/resources-reimbursement/technical-resources/product-performance-reports/2016_1sted_05052016_b.pdf. Дата обращения: 07.08.2016 г. [Available from https://www.sjm.com/w/media/galaxy/hcp/resources-reimbursement/technical-resources/product-performance-reports/2016_1sted_05052016_b.pdf. Accessed August 7]
  16. Kramer D.B., Hatfield L.A., McGriff D., Ellis C.R., Gura M.T., Samuel M., Retel L.K., Hauser R.G. Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance. J Am Heart Assoc. 2015;4(6):e001672. PMID: 26025935, PMCID: PMC4599526. https://doi.org/10.1161/JAHA.114.001672
  17. Tzogias L., Bellavia D., Sharma S., Donohue T.J., Schoenfeld M.H. Natural history of the Sprint Fidelis lead: survival analysis from a large single-center study. J Interv Card Electrophysiol. 2012;34(1):37-44. PMID: 22314669. https://doi.org/10.1007/s10840-011-9647-0
  18. Ellenbogen K.A., Gunderson B.D., Stromberg K.D., Swerdlow C.D. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads. Circ Arrhythm Electrophysiol. 2013;6(6):1169-77. PMID: 24099976. https://doi.org/10.1161/CIRCEP.113.000744
  19. Janson C.M., Patel A.R., Bonney W.J., Smoots K., Shah M.J. Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design? J Am Coll Cardiol. 2014;63(2):133-40. PMID: 24140671. https://doi.org/10.1016/j.jacc.2013.09.033
  20. Hauser R.G., Maron B.J., Marine J.E., Lampert R., Kadish A.H., Winters S.L., Scher D.L., Biria M., Kalia A. Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients. Heart Rhythm. 2008;5(11):1517-22. PMID: 18984525. https://doi.org/10.1016/j.hrthm.2008.08.021
  21. Borleffs C.J.W., van Erven L., van Bommel R.J., van der Velde E.T., van der Wall E.E., Bax J.J., Rosendaal F.R., Schalij M.J. Risk of failure of transvenous implantable cardioverter-defibrillator leads. Circ Arrhythm Electrophysiol. 2009;2(4):411-6. PMID: 19808497. https://doi.org/10.1161/CIRCEP.108.834093
  22. Hauser R.G., Hayes D.L. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2009;6(5):605-10. PMID: 19285920. https://doi.org/10.1016/j.hrthm.2009.02.024
  23. Sung R.K., Massie B.M., Varosy P.D., Moore H., Rumsfeld J., Lee B.K., Keung E. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm. 2012;9(12):1954-61. PMID: 22871583. https://doi.org/10.1016/j.hrthm.2012.08.006
  24. Faulknier B.A., Traub D.M., Aktas M.K., Aguila A., Rosero S., Daubert J.P., Hall B., Shah A., Taylor S., McNitt S., Moss A.J., Zareba W., Huang DT. Time-dependent risk of Fidelis lead failure. Am J Cardiol. 2010;105(1):95-9. PMID: 20102898. https://doi.org/10.1016/j.amjcard.2009.08.655
  25. Berul C.I., Van Hare G., Kertesz N.J., Dubin A.M., Cecchin F., Collins K.K., Cannon B.C., Alexander M.E., Triedman J.K., Walsh E.P., Friedman R.A. Results of a multicenter retrospective implantable cardioverter defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51(17):1685-91. PMID: 18436121. https://doi.org/10.1016/j.jacc.2008.01.033
  26. Atallah J., Erickson C.C., Cecchin F., Dubin A.M., Law I.H., Cohen M.I., Lapage M.J., Cannon B.C., Chun T.U., Freedenberg V., Gierdalski M., Berul C.I.; Pediatric and Congenital Electrophysiology Society (PACES). A multi-institutional study of implantable defibrillator lead performance in children and young adults: Results of the pediatric lead extractability and survival evaluation (PLEASE) study. Circulation. 2013;127(24):2393-402. PMID: 23694966. https://doi.org/10.1161/CIRCULATIONAHA.112.001120
  27. Gadler F, Valzania C, Linde C. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Europace. 2015;17(1):69-77. PMID: 25336667. https://doi.org/10.1093/europace/euu233
  28. Li X., Ze F., Wang L., Li D., Duan J., Guo F., Yuan C., Li Y., Guo J. Prevalence of venous occlusion in patients referred for lead extraction: implications for tool selection. Europace. 2014;16(12):1795-9. PMID: 24948591. https://doi.org/10.1093/europace/euu124
  29. Bongiorni M.G., Dagres N., Estner H., Pison L., Todd D., Blomstrom-Lundqvist C.; Scientific Initiative Committee, European Heart Rhythm Association. Management of malfunctioning and recalled pacemaker and defibrillator leads: results of the European Heart Rhythm Association survey. Europace. 2014;16(11):1674-8. PMID: 25344962. https://doi.org/10.1093/europace/euu302